RxDoctor Payments Data

David Pointer, MD

Surgical Oncology · New Orleans, LANPI 1356601645

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (57.0%), food and beverage and education — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Histosonics, Inc. at 43.2% of the total. 2025 is the largest year on record at $2,157, more than ten times the $47 reported in 2020.

$3,655in general payments, 2019–2025

Across 29 payments — averaging $126.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Histosonics, Inc.$2K
  • Intuitive Surgical$805
  • Medtronic$282
  • AstraZeneca$231
  • Intera Oncology, Inc$202
  • Trisalus Life Sciences, Inc.$160
  • plus $396 from 11 others

What the payments were for

  • Travel & lodging$2,08357%
  • Food & beverage$1,49541%
  • Education$682%
  • Gifts$90%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,655 in reported general payments places this provider in the 70th percentile of 26 surgical oncology providers in Louisiana.

See all surgical oncology providers in Louisiana

Medicare billing

Part B allowed, 2024
$58,707
Medicare patients
68
Services billed
215

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other surgical oncology in New Orleans

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →